Home Featured Page 143

Featured

Latest

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Optimi Health Provides Progress Report On Year Of Commercialization

FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN...

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of...

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine...

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment...

Optimi Health Enters Into International Collaborative Research and Supply Agreement With...

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Mindset Pharma to Participate in the H.C. Wainwright 24th Annual Global...

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....

1...142143144...296 Page 143 of 296

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Optimi Health Provides Progress Report On Year Of Commercialization

FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN...

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of...

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine...

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment...

Optimi Health Enters Into International Collaborative Research and Supply Agreement With...

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Mindset Pharma to Participate in the H.C. Wainwright 24th Annual Global...

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY